Gene Writing Technology Global Market Report 2026

Gene writing technology encompasses advanced biotechnological methods for designing, synthesizing, and accurately assembling DNA sequences, allowing scientists to create, modify, or insert genes with high precision. This technology focuses on constructing new genetic sequences from scratch or rewriting long DNA segments, supporting applications in synthetic biology, medicine, agriculture, and biotechnology.

The key technologies of gene writing include chemical DNA synthesis and enzymatic DNA synthesis. Chemical DNA synthesis refers to artificially creating DNA sequences from nucleotides in the lab without using living cells. Product types include gene editing tools, gene synthesis platforms, delivery systems, and others. Applications include therapeutics, research, agriculture, and diagnostics, serving pharmaceutical and biotechnology companies, academic and research institutes, hospitals and clinics, and other end-users.

Tariffs on imported laboratory instruments, synthesis reagents, and precision equipment have impacted the gene writing technology market by increasing operational and production costs, particularly affecting chemical and enzymatic DNA synthesis segments. Regions such as North America and Europe that rely on globally sourced biotech equipment and reagents are most affected. Pharmaceutical and biotechnology companies may face higher research and manufacturing expenses. However, tariffs are also encouraging domestic production of synthesis platforms and reagents, strengthening local biotech ecosystems and promoting regional innovation in synthetic biology and precision medicine.

The gene writing technology market research report is one of a series of new reports from The Business Research Company that provides gene writing technology market statistics, including gene writing technology industry global market size, regional shares, competitors with a gene writing technology market share, detailed gene writing technology market segments, market trends and opportunities, and any further data you may need to thrive in the gene writing technology industry. This gene writing technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene writing technology market size has grown exponentially in recent years. It will grow from $5.62 billion in 2025 to $7 billion in 2026 at a compound annual growth rate (CAGR) of 24.5%. The growth in the historic period can be attributed to advancement in chemical DNA synthesis techniques, growth in genomics research funding, rising demand for gene editing applications, expansion of biopharmaceutical research activities, increasing adoption of synthetic biology tools.

The gene writing technology market size is expected to see exponential growth in the next few years. It will grow to $16.97 billion in 2030 at a compound annual growth rate (CAGR) of 24.8%. The growth in the forecast period can be attributed to growing development of gene-based therapeutics, increasing automation in DNA synthesis platforms, rising investment in agricultural biotechnology innovation, expanding use of AI-driven gene design tools, increasing demand for scalable and cost-efficient DNA manufacturing. Major trends in the forecast period include increasing adoption of enzymatic DNA synthesis methods, growing demand for long-sequence DNA assembly, rising investment in synthetic biology platforms, expansion of custom gene design services, growing integration of automated gene synthesis workflows.

The expansion in gene therapy development is anticipated to drive the growth of the gene writing technology market in the coming years. Gene therapy development refers to the rising research activities, clinical trials, and regulatory approvals of therapies that aim to treat or correct genetic disorders by modifying genes. This development is accelerating due to rapid progress in genetic engineering technologies and supportive regulatory frameworks that facilitate more therapies moving from research to clinical trials and approvals. Gene writing technology aids gene therapy development by offering precise, efficient, and programmable tools to edit, insert, or correct specific genes, allowing the creation of safer and more effective treatments for a broad range of genetic conditions. For example, in January 2024, according to the American Society of Gene & Cell Therapy, a US-based organization for gene and cell therapy, in the fourth quarter (Q4) of 2023, the number of gene therapies in Phase III rose by 10% compared to the previous quarter, marking the first increase since the third quarter (Q3) of 2022. Therefore, the growth in gene therapy development is fueling the expansion of the gene writing technology market.

Leading companies operating in the gene writing technology market are focusing on developing innovative solutions such as in vivo gene editing therapy to precisely correct disease-causing genes and provide durable treatments for genetic disorders. In vivo gene editing therapy is a treatment that directly modifies a patient's genes inside their body to correct disease-causing mutations, helping to deliver precise, long-lasting solutions for genetic disorders without the need for repeated treatments. For example, in January 2026, Tessera Therapeutics Inc., a US-based biotechnology company, announced the advancement of TSRA-196, an in vivo gene writing-based therapy targeting alpha-1 antitrypsin deficiency (AATD). TSRA-196 is designed for intravenous administration using the company's proprietary lipid nanoparticle delivery system to deliver RNA to liver cells. Built on a target-primed reverse transcription (TPRT) platform, the therapy is intended to permanently correct the underlying SERPINA1 gene mutation, with the potential to restore functional AAT protein expression. This approach aims to overcome the limitations of conventional augmentation therapies, which provide only temporary symptomatic relief.

In February 2024, Intellia Therapeutics Inc., a US-based clinical-stage gene editing company focused on providing gene writing technology, formed a partnership with ReCode Therapeutics Inc. to develop innovative gene editing therapies for cystic fibrosis (CF). Through this collaboration, Intellia Therapeutics, Inc. and ReCode Therapeutics, Inc. plan to merge Intellia's CRISPR-based DNA editing technology with ReCode's Selective Organ Targeting (SORT) lipid nanoparticle delivery platform to accurately correct CF-causing gene mutations, enhance treatment options for patients with limited therapies, and speed up the development of next-generation gene editing therapeutics. ReCode Therapeutics Inc. is a US-based company concentrating on targeted delivery of genetic medicines using LNP technology for both rare and common diseases.

Major companies operating in the gene writing technology market are Beam Therapeutics Inc., Twist Bioscience Corporation, Sangamo Therapeutics Inc., Editas Medicine Inc., Tessera Therapeutics Inc., Precision BioSciences Inc., Metagenomi Inc., Mammoth Biosciences Inc., Synbio Technologies Inc., Arbor Biotechnologies Inc., Intellia Therapeutics Inc., Inscripta Inc., Edigene Inc., Recombinetics Inc., Pairwise Plants Inc., Caribou Biosciences Inc., GenEdit Inc., BRL Medicine Inc., Eligo Bioscience Inc., Prime Medicine Inc., ToolGen Inc., iECURE Inc., Cellectis S.A.

North America was the largest region in the gene writing technology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene writing technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the gene writing technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene writing technology market consists of revenues earned by entities by providing services such as designing, synthesizing, and editing genetic sequences, developing customized gene constructs, delivering genome engineering solutions, and offering consulting or support for precise genetic modifications. The market value includes the value of related goods sold by the service provider or included within the service offering. The gene writing technology market consists of sales of gene synthesis platforms, genome editing tools, gene writing software, related reagents and kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Writing Technology Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses gene writing technology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene writing technology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene writing technology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Technology: Chemical Deoxyribonucleic Acid Synthesis; Enzymatic Deoxyribonucleic Acid Synthesis
• 2) By Product Type: Gene Editing Tools; Gene Synthesis Platforms; Delivery Systems; Other Product Types
• 3) By Application: Therapeutics; Research; Agriculture; Diagnostics
• 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Hospitals And Clinics; Other End Users
• Subsegments:
• 1) By Chemical Deoxyribonucleic Acid Synthesis: Solid Phase Synthesis; Liquid Phase Synthesis; Microarray Based Synthesis; Chip Based Synthesis
• 2) By Enzymatic Deoxyribonucleic Acid Synthesis: Polymerase Mediated Synthesis; Ligase Mediated Synthesis; Recombinase Mediated Synthesis; Template Independent Synthesis
• Companies Mentioned: Beam Therapeutics Inc.; Twist Bioscience Corporation; Sangamo Therapeutics Inc.; Editas Medicine Inc.; Tessera Therapeutics Inc.; Precision BioSciences Inc.; Metagenomi Inc.; Mammoth Biosciences Inc.; Synbio Technologies Inc.; Arbor Biotechnologies Inc.; Intellia Therapeutics Inc.; Inscripta Inc.; Edigene Inc.; Recombinetics Inc.; Pairwise Plants Inc.; Caribou Biosciences Inc.; GenEdit Inc.; BRL Medicine Inc.; Eligo Bioscience Inc.; Prime Medicine Inc.; ToolGen Inc.; iECURE Inc.; Cellectis S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.